Announcements Trials
Browse Landscape

Phase

Phase 4 9Phase NA 4Phase 3 4Phase EARLY_PHASE1 2Phase 2 2Phase 1 2Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Polycystic Ovary Syndrome 1Obesity 1

Interventions

tegaserod 1semaglutide 1penclomedine 1aluminum hydroxide, magnesium hydroxide, drug combination 1Thioctic Acid 1Tablets 1Radiation 1Metformin 1Megestrol Acetate 1Low-Level Light Therapy 1Lidocaine 1Letrozole 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Exercise 1Exenatide 1Diphenhydramine 1Buspirone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Metformin × Other × Clear all
NCT06896981 2025-04-02

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase 2/3 Recruiting
30 enrolled
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡